cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Biomea Fusion Inc
5 own
6 watching
Current Price
$11.5
$-0.45
(-3.77%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
608.61M
52-Week High
52-Week High
43.69000
52-Week Low
52-Week Low
8.12500
Average Volume
Average Volume
0.7M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization608.61M
icon52-Week High43.69000
icon52-Week Low8.12500
iconAverage Volume0.7M
iconDividend Yield--
iconP/E Ratio--
What does the Biomea Fusion Inc do?
Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of irreversible small molecules to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective irreversible inhibitor of menin, a transcriptional regulator in oncogenic signaling in multiple cancers. The company was incorporated in 2017 and is headquartered in Redwood City, California.
Read More
How much money does Biomea Fusion Inc make?
News & Events about Biomea Fusion Inc.
PR Newswire
9 months ago
BMEA ALERT: The Law Offices of Vincent Wong Investigate Biomea Fusion, Inc. for Potential Violations of Securities Laws BMEA ALERT: The Law Offices of Vincent Wong Investigate Biomea Fusion, Inc. for Potential Violations of Securities Laws PR Newswire NEW YORK, July 3, 2023 NEW YORK, July 3, 2023...
Stock Options Channel
9 months ago
Investors considering a purchase of Biomea Fusion Inc (BMEA) stock, but cautious about paying the going market price of 21.60/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the January 2024 ...
PR Newswire
9 months ago
Thinking about trading options or stock in Apple, C3is, Biomea Fusion, PayPal, or SL Green Realty? Thinking about trading options or stock in Apple, C3is, Biomea Fusion, PayPal, or SL Green Realty? PR Newswire NEW YORK, June 26, 2023 NEW YORK, June 26, 2023 /PRNewswire/ -- InvestorsObserver issues...
Globe Newswire
9 months ago
Eight weeks after completing treatment with BMF-219, patients with type 2 diabetes (T2D) showed an increase of C-peptide and an improvement of HOMA-B, measured during oral glucose tolerance testing (OGTT), supporting improved beta cell function for these patientsObservations of durable and continued...
Globe Newswire
11 months ago
BMF-500, a novel 3rd generation covalent inhibitor of fms-like tyrosine kinase 3 (FLT3), is the second investigational compound, discovered and developed by Biomeas FUSION System, to advance to the clinic.Phase I study (COVALENT-103) of BMF-500 will examine its safety and efficacy in patients with ...
Frequently Asked Questions
Frequently Asked Questions
What is Biomea Fusion Inc share price today?
plus_minus_icon
Can Indians buy Biomea Fusion Inc shares?
plus_minus_icon
How can I buy Biomea Fusion Inc shares from India?
plus_minus_icon
Can Fractional shares of Biomea Fusion Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Biomea Fusion Inc stocks?
plus_minus_icon
What is today’s traded volume of Biomea Fusion Inc?
plus_minus_icon
What is today’s market capitalisation of Biomea Fusion Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Biomea Fusion Inc?
plus_minus_icon
What percentage is Biomea Fusion Inc down from its 52-Week High?
plus_minus_icon
What percentage is Biomea Fusion Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$11.5
$-0.45
(-3.77%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00